For research use only. Not for therapeutic Use.
Trifluoperazine N-glucuronide-d3, a premium pharmaceutical research compound designed for advanced psychopharmacological and metabolic studies. As a deuterated analog of Trifluoperazine N-glucuronide, it offers enhanced stability and improved isotopic tracking. Trifluoperazine N-glucuronide-d3 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for psychiatric disorders and in the study of drug metabolism. Trusted by leading laboratories, Trifluoperazine N-glucuronide-d3 is your go-to solution for cutting-edge mental health and metabolic research. Unlock new possibilities in the treatment of psychiatric disorders and drug metabolism studies with Trifluoperazine N-glucuronide-d3, where innovation meets reliability.
| Catalog Number | S000173 |
| Molecular Formula | C27H29D3F3N3O6S |
| Purity | ≥95% |
| IUPAC Name | (2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[1-(trideuteriomethyl)-4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-ium-1-yl]oxane-2-carboxylate |
| InChI | InChI=1S/C27H32F3N3O6S/c1-33(25-23(36)21(34)22(35)24(39-25)26(37)38)13-11-31(12-14-33)9-4-10-32-17-5-2-3-6-19(17)40-20-8-7-16(15-18(20)32)27(28,29)30/h2-3,5-8,15,21-25,34-36H,4,9-14H2,1H3/t21-,22-,23+,24-,25+/m0/s1/i1D3 |
| InChIKey | AFYPHWNGUDUHIW-WSDLWNSTSA-N |
| SMILES | [2H]C([2H])([2H])[N+]1(CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)[O-])O)O)O |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Fujiwara R, et al. Interactions between human UGT1A1, UGT1A4, and UGT1A6 affect their enzymatic activities. Drug Metab Dispos. 2007;35(10):1781-1787 |
